WallStreetZenWallStreetZen

NASDAQ: ARDX
Ardelyx Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for ARDX

Based on 2 analysts offering 12 month price targets for Ardelyx Inc.
Min Forecast
$5.00+174.73%
Avg Forecast
$6.50+257.14%
Max Forecast
$8.00+339.56%

Should I buy or sell ARDX stock?

Based on 3 analysts offering ratings for Ardelyx Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
0 analysts 0%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ARDX stock forecasts and price targets.

ARDX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Piper Sandler
Top 27%
74
Strong BuyUpgrades$8.00+339.56%2022-11-17
Cantor Fitzgerald
Bottom 5%
5
HoldDowngradesN/AN/A2022-05-06
Jefferies
Bottom 5%
5
Strong BuyUpgrades$5.00+174.73%2022-03-02

1 of 1

Forecast return on equity

Is ARDX forecast to generate an efficient return?
Company
120.56%
Industry
13.69%
Market
62.68%
ARDX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ARDX forecast to generate an efficient return on assets?
Company
55.72%
Industry
13.17%
ARDX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ARDX earnings per share forecast

What is ARDX's earnings per share in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
-$0.70
Avg 2 year Forecast
-$0.36
Avg 3 year Forecast
-$0.04

ARDX revenue forecast

What is ARDX's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$10.4M+14.96%
Avg 2 year Forecast
$31.0M+244.43%
Avg 3 year Forecast
$120.6M+1,238.76%
ARDX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ARDX revenue growth forecast

How is ARDX forecast to perform vs Biotechnology companies and vs the US market?
Company
129.66%
Industry
24.03%
Market
6.67%
ARDX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ARDX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ARDX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ARDX$1.82$6.50+257.14%Strong Buy
WVE$3.90$5.33+36.74%Hold
ORMP$8.64$25.00+189.35%Strong Buy
CNTA$3.65$6.67+82.66%Hold
QSI$2.40$13.00+441.67%Strong Buy

Ardelyx Stock Forecast FAQ

Is Ardelyx Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ARDX) stock is to Strong Buy ARDX stock.

Out of 3 analysts, 2 (66.67%) are recommending ARDX as a Strong Buy, 0 (0%) are recommending ARDX as a Buy, 1 (33.33%) are recommending ARDX as a Hold, 0 (0%) are recommending ARDX as a Sell, and 0 (0%) are recommending ARDX as a Strong Sell.

If you're new to stock investing, here's how to buy Ardelyx stock.

What is ARDX's earnings growth forecast for 2022-2024?

(NASDAQ: ARDX) Ardelyx's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.77%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.05%.

Ardelyx's earnings in 2022 is -$114,136,000.On average, 6 Wall Street analysts forecast ARDX's earnings for 2022 to be -$131,221,752, with the lowest ARDX earnings forecast at -$149,967,716, and the highest ARDX earnings forecast at -$112,475,787. On average, 6 Wall Street analysts forecast ARDX's earnings for 2023 to be -$67,485,472, with the lowest ARDX earnings forecast at -$138,720,137, and the highest ARDX earnings forecast at $5,623,789.

In 2024, ARDX is forecast to generate -$7,498,386 in earnings, with the lowest earnings forecast at -$82,482,244 and the highest earnings forecast at $54,363,297.

What is ARDX's revenue growth forecast for 2022-2024?

(NASDAQ: ARDX) Ardelyx's forecast annual revenue growth rate of 129.66% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 24.03%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 6.67%.

Ardelyx's revenue in 2022 is $9,009,000.On average, 3 Wall Street analysts forecast ARDX's revenue for 2022 to be $1,941,519,543, with the lowest ARDX revenue forecast at $564,253,531, and the highest ARDX revenue forecast at $4,217,842,013. On average, 3 Wall Street analysts forecast ARDX's revenue for 2023 to be $5,816,872,784, with the lowest ARDX revenue forecast at $187,459,645, and the highest ARDX revenue forecast at $14,790,565,991.

In 2024, ARDX is forecast to generate $22,609,320,324 in revenue, with the lowest revenue forecast at $14,229,686,733 and the highest revenue forecast at $27,500,329,922.

What is ARDX's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: ARDX) forecast ROA is 55.72%, which is higher than the forecast US Biotechnology industry average of 13.17%.

What is ARDX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ARDX price target, the average ARDX price target is $6.50, with the highest ARDX stock price forecast at $8.00 and the lowest ARDX stock price forecast at $5.00.

On average, Wall Street analysts predict that Ardelyx's share price could reach $6.50 by Nov 17, 2023. The average Ardelyx stock price prediction forecasts a potential upside of 257.14% from the current ARDX share price of $1.82.

What is ARDX's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: ARDX) Ardelyx's current Earnings Per Share (EPS) is -$0.85. On average, analysts forecast that ARDX's EPS will be -$0.70 for 2022, with the lowest EPS forecast at -$0.80, and the highest EPS forecast at -$0.60. On average, analysts forecast that ARDX's EPS will be -$0.36 for 2023, with the lowest EPS forecast at -$0.74, and the highest EPS forecast at $0.03. In 2024, ARDX's EPS is forecast to hit -$0.04 (min: -$0.44, max: $0.29).

What is ARDX's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: ARDX) forecast ROE is 120.56%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.